Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SMEDEFIRMAET MOEL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8%   Bankruptcy risk   6.1% 9.6% 12.1% 5.6% 9.8% 13.2% 17.3% 17.2%   Credit score (0-100)   40 25 18 40 24 17 9 10   Credit rating   BBB BB BB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,205 3,864 3,068 4,473 4,717 2,975 0.0 0.0   EBITDA   -136 1,094 -198 798 675 -630 0.0 0.0   EBIT   -172 976 -334 658 532 -798 0.0 0.0   Pre-tax profit (PTP)   -200.2 921.1 -347.7 673.7 486.2 -826.1 0.0 0.0   Net earnings   -157.6 712.8 -365.1 612.9 374.9 -826.1 0.0 0.0   Pre-tax profit without non-rec. items   -200 921 -348 674 486 -826 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   310 498 469 328 233 122 0.0 0.0   Shareholders equity total   222 935 -29.9 583 798 -178 -428 -428   Interest-bearing liabilities   43.1 0.0 668 708 57.3 669 428 428   Balance sheet total (assets)   1,311 3,061 2,423 2,527 2,475 1,391 0.0 0.0   Net Debt   43.1 -737 668 708 57.3 669 428 428     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,205 3,864 3,068 4,473 4,717 2,975 0.0 0.0   Gross profit growth   -24.8% 20.6% -20.6% 45.8% 5.4% -36.9% -100.0% 0.0%   Employees   9 9 9 8 8 8 0 0   Employee growth %   0.0% 0.0% 0.0% -11.1% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,311 3,061 2,423 2,527 2,475 1,391 0 0   Balance sheet change%   -52.4% 133.6% -20.9% 4.3% -2.1% -43.8% -100.0% 0.0%   Added value   -135.6 1,094.4 -198.1 798.2 672.8 -629.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   217 69 -165 -281 -238 -280 -122 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -5.4% 25.2% -10.9% 14.7% 11.3% -26.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.4% 44.6% -11.8% 28.3% 21.3% -38.2% 0.0% 0.0%   ROI %   -24.0% 162.5% -39.3% 70.3% 49.6% -101.3% 0.0% 0.0%   ROE %   -33.7% 123.2% -21.7% 40.8% 54.3% -75.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   17.0% 30.5% -1.2% 23.1% 32.2% -11.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -31.7% -67.3% -337.4% 88.7% 8.5% -106.3% 0.0% 0.0%   Gearing %   19.4% 0.0% -2,232.2% 121.4% 7.2% -375.7% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.7% 252.9% 7.0% 4.5% 12.1% 14.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.8 1.2 0.8 1.1 1.3 0.8 0.0 0.0   Current Ratio   0.8 1.2 0.8 1.1 1.3 0.8 0.0 0.0   Cash and cash equivalent   0.0 736.7 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -193.5 371.3 -519.1 236.0 547.0 -316.2 -214.1 -214.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -15 122 -22 100 84 -79 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -15 122 -22 100 84 -79 0 0   EBIT / employee   -19 108 -37 82 67 -100 0 0   Net earnings / employee   -18 79 -41 77 47 -103 0 0